Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Novartis
Kivu Bioscience Inc.
Hoffmann-La Roche
Institut Bergonié
City of Hope Medical Center
Bayer
University of California, Irvine
M.D. Anderson Cancer Center
Eastern Cooperative Oncology Group
ViroMissile, Inc.
Dana-Farber Cancer Institute
Kaiser Permanente
University of Florida
Essen Biotech
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
MacroGenics
Indiana University
National Cancer Institute (NCI)
City of Hope Medical Center
Fred Hutchinson Cancer Center
Perspective Therapeutics
M.D. Anderson Cancer Center
Ocellaris Pharma, Inc.
Eli Lilly and Company
Var2 Pharmaceuticals
M.D. Anderson Cancer Center
UNICANCER
Memorial Sloan Kettering Cancer Center
Mayo Clinic
Tanabe Pharma America, Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
HiFiBiO Therapeutics
Seattle Children's Hospital
Seattle Children's Hospital
Tango Therapeutics, Inc.
Bayer
National Institutes of Health Clinical Center (CC)
St. Jude Children's Research Hospital
Sarcoma Alliance for Research through Collaboration
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
St. Jude Children's Research Hospital
HiFiBiO Therapeutics